Defibrillator Market

Defibrillator Market by Product Type (Implantable Cardioverter Defibrillator [Single Chamber ICD, Dual Chamber ICD, CRT-D, Subcutaneous ICD (S-ICD)], and External Defibrillator [Semi-Automated, Automated, and Wearable]), End-User (Hospitals, Ambulatory Surgical Centers, Homecare Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing cases of cardiovascular disorders and the rising product developmental activities worldwide

The defibrillators market was valued at USD 10.19 billion in 2023, growing at a CAGR of 3.11% during the forecast period from 2025 to 2032, to reach USD 12.24 billion by 2032. The defibrillator market is observing substantial market growth primarily owing to the increasing cases of chronic disorders such as cardiovascular diseases including atrial fibrillation and coronary artery disease (CAD), innovative product developmental activities by leading companies, and the rising geriatric population are expected to escalate the overall growth of the defibrillators market during the forecast period from 2025 to 2032.

Defibrillators Market Dynamics:

As per recent data provided by the World Heart Report (2023), in 2021 it was stated that more than half a billion people were living with cardiovascular diseases globally. Further, according to recent data provided by the American Heart Association (2023), it is estimated that by 2030 over 12 million people will have atrial fibrillation globally.

According to British Heart Foundation, Global Heart & Circulatory Diseases Factsheet (2024), it stated that around 200 million people are living with CAD around the world.

Defibrillators are crucial in managing cardiovascular diseases and conditions like atrial fibrillation and CAD. For individuals experiencing sudden cardiac arrest, defibrillators can deliver an electric shock to restore a normal heart rhythm, which is vital in emergencies. In cases of atrial fibrillation, where the heart's rhythm becomes irregular, defibrillators can be used to reset the heart’s rhythm to its normal state. Defibrillators can be life-saving in instances where CAD leads to cardiac arrest. Their use helps improve survival rates by providing timely intervention and increasing the chances of successful resuscitation during critical moments.

Increased product developmental activities by regulatory bodies worldwide are also slated to witness market growth for defibrillators. For example, in January 2024, Element Science received a CE mark in Europe and approval in the U.K. for its patch-based cardioverter defibrillator, designed to offer a more wearable option for individuals at risk of sudden cardiac arrest who may not qualify for or prefer not to have a long-term implant. In addition to this, in October 2023, Medtronic plc received FDA approval for its Aurora EV-ICD™ MRI SureScan™ Extravascular Implantable Cardioverter-defibrillator and Epsila EV™ MRI SureScan™ defibrillation lead. These devices are designed to treat dangerously fast heart rhythms that can lead to sudden cardiac arrest.

As per data provided by the World Health Organization 2021, between 2015 and 2050, people falling between 60 years and above will be doubled from 12 to 22%, and will eventually reach 2.1 billion by the year 2050, globally. Moreover, by 2030, 1 in 6 people will age 60 years or above. As the global population ages, with a significant increase in individuals over 60 years old, who are more susceptible to cardiac events, defibrillators play a vital role in emergency medical care. They are used to restore normal heart rhythms in cases of sudden cardiac arrest, which is more common in older adults due to age-related health conditions. By providing immediate, life-saving intervention, defibrillators can significantly improve survival rates and outcomes for the elderly, making them an essential component of emergency response systems in aging societies.

Therefore, the factors stated above collectively will drive the overall defibrillator market growth.

However, electric shock delivered by defibrillators associated with burns or skin damage at the electrode site, and others may prove to be challenging factors for the defibrillators market growth.

Defibrillators Market Segment Analysis:

Defibrillator Market by Product Type (Implantable Cardioverter Defibrillator [Single Chamber ICD, Dual Chamber ICD, CRT-D, Subcutaneous ICD (S-ICD)], and External Defibrillator [Semi-Automated, Automated, and Wearable]), End-User (Hospitals, Ambulatory Surgical Centers, Homecare Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product type segment of the defibrillators market, the external defibrillator category is expected to have a significant revenue share in the year 2023. This is because of the widespread uses and various advantages of external defibrillators that enhance their utility and effectiveness.

External defibrillators are devices used to treat sudden cardiac arrest by delivering an electric shock to the heart. Their advantages include their ability to provide immediate intervention during a cardiac emergency, which significantly increases the chances of survival. Additionally, modern defibrillators often come equipped with data recording capabilities that can aid in post-event analysis and patient care.

Furthermore, technological advancements and product innovations taking place in the development of external defibrillators are likely to propel the defibrillator market growth. For instance, in January 2023, Avive Solutions, Inc., received U.S. Food and Drug Administration (FDA) pre-market approval (PMA for its Avive AED™, a unique Automated External Defibrillator (AED).

Therefore, the widespread uses and various advantages of external defibrillators enhance performance and usability, solidifying the significant impact on the growth of the overall defibrillators market during the forecast period from 2025 to 2032.

North America is expected to dominate the overall defibrillator market:

Among all the regions, North America is expected to dominate the defibrillators market in the year 2023 and is expected to do the same during the forecast period from 2025 to 2032. This can be attributed to several factors including the high prevalence of coronary artery disease, myocardial infarctions, and other heart conditions, along with associated risk factors for cardiovascular disorders, combined with significant advancements in product development and regulatory approvals are acting as key factors contributing to the growth of the defibrillators market in the North America region during the forecast period from 2025 to 2032.

As per data provided by the National Institute of Health (2023), it stated that 20.5 million people in the US were living with CAD. Furthermore, according to data from the Centers for Disease Control and Prevention (CDC) (2024), it was stated that 805,000 people in the US have a myocardial infarction (heart attack) every year on average. Furthermore, as per the same source, it was stated that heart disease is an umbrella term that encompasses numerous indications such as acute coronary syndrome, atherosclerosis, and congestive heart failure among others. Some of the key risk factors associated with heart disease are high blood cholesterol, high blood pressure, and smoking. The source further mentioned that about half of Americans (47%) have at least one of these three risk factors.

According to data from the Canadian Institute for Health Information (2024), it stated that in 2022, 2.4 million Canadians were affected by heart disease. Defibrillators play a critical role in managing severe heart conditions such as CAD and myocardial infarction (heart attack). They are used to restore a normal heart rhythm during sudden cardiac arrest, a potential complication of these conditions. Defibrillators can be found in various settings, including public spaces, hospitals, and emergency response kits. Their ability to provide immediate electrical shocks to the heart can significantly improve survival rates and outcomes in cardiac emergencies. In cases of heart disease, where patients may experience irregular heart rhythms or sudden cardiac arrest, defibrillators are essential tools for prompt intervention and treatment.

Rising product developmental activities by regulatory bodies in the region will further boost the market for defibrillators. For example, in August 2021, Kestra™ Medical Technologies, Inc. announced that the company received premarket approval from the U.S. Food and Drug Administration (FDA) for the ASSURE® Wearable Cardioverter Defibrillator system. 

Therefore, the interplay of all the aforementioned factors would provide a conducive growth environment for the North America defibrillators market.

Defibrillators Market key players:

Some of the key market players operating in the defibrillators market include Abbott, Medtronic, Boston Scientific Corporation, Stryker, Koninklijke Philips N.V, Zoll Medical Corporation, Microport Scientific Corporation, LivaNova PLC, Biotronik, Inc., Nihon Kohden Corporation, SCHILLER AG, Bexen Cardio, Progetti S.r.l., BPL Medical Technologies, Shenzhen Comen Medical Instruments Co., Ltd, and others.

Recent Developmental Activities in the Defibrillators Market:

• In June 2024, Stryker announced the launch of its latest product in the monitor/defibrillator space, the LIFEPAK 35 monitor/defibrillator. The device was designed to support life-saving teams by providing real-time access to critical patient information. Built on an intuitive, modern platform, the LIFEPAK 35 aimed to advance patient care. It featured a slim, light, and ergonomic design, along with a large intuitive touchscreen.
• In June 2024, Elutia Inc., a pioneer in drug-eluting biomatrix products, announced that Antibiotic-Eluting BioEnvelope, EluPro (previously known as CanGaroo during development), received clearance from the U.S. Food and Drug Administration (FDA). Designed to prevent post-operative complications for devices like pacemakers and defibrillators, EluPro integrated potent antibiotic therapy with advanced tissue engineering. This BioEnvelope was created to gradually regenerate into a protective pocket of the patient's own tissue over time.
• In January 2024, Speedy Hire launched a life-saving initiative by installing defibrillators in its engineer vans nationwide. Initially starting with 18 defibrillators, the rollout aimed to place over 300 new portable defibrillators in the vans of Speedy Hire’s engineers once completed.
• In June 2021, Rapid Response Revival (RRR) earned CE mark certification in Europe for their automated external defibrillator (AED), CellAED.

Key Takeaways from the Defibrillators Market Report Study

• Market size analysis for current defibrillators market size (2023), and market forecast (2025 to 2032)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years
• Key companies dominating the defibrillators market.
• Various opportunities are available for the other competitors in the defibrillator market space.
• What are the top-performing segments in 2023? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current defibrillators market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for defibrillator market growth in the coming future?

Target Audience who can be benefited from this Defibrillators Market Report Study

• Defibrillators product providers
• Research organizations and consulting companies
• Defibrillators-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in defibrillators
• Various end-users want to know more about the defibrillator market and the latest technological developments in the defibrillator market.